Reacción #674301

ord-749c7922180843858bf7d075f1e23362

Ecuación de reacción

CS(=O)(=O)Cl
Methanesulfonyl chloride
[Cl-].[NH4+]
NH4Cl
CCN(CC)CC
Et3N
CCN(CC)CC
Et3N
CS(=O)(=O)Cl
methanesulfonyl chloride
CC(C)(C)OC(=O)N1CCC2(CC1)CC(O)C2
tert-butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate
CC(C)(C)OC(=O)N1CCC2(CC1)CC(OS(C)(=O)=O)C2
tert-butyl 2-(methylsulfonyloxy)-7-azaspiro[3.5]nonane-7-carboxylate
Rendimiento 93.1%

Disolventes

Condiciones de reacción

Temperatura
0°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Temperaturato warm to room temperature
  2. 2
    workup.STIRRINGstirred at room temperature for 18 hrs
  3. 3
    workup.STIRRINGthe mixture was stirred for another 6 h
  4. 4
    workup.STIRRINGstirred at room temperature for 10 min
  5. 5
    OtroThe layers were separated
  6. 6
    ExtracciónThe aqueous phase was extracted with DCM (3×30 mL)
  7. 7
    LavadoThe combined organic phase were washed with HCl (1N, 20 mL) and water (20 mL)
  8. 8
    Secadowere dried over anhydrous Na2SO4
  9. 9
    Concentraciónconcentrated in vacuo

Procedimiento

tert-butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate (392 mg, 1.62 mmol, 1.0 equiv) was dissolved in DCM (6.0 mL). The solution was cooled to 0° C. with an external ice-bath. Et3N (237 μL, 1.706 mmol, 1.05 equiv)) and DMAP (2.0 mg, 1 mol %) were added. Methanesulfonyl chloride (132 μL, 1.706 mmol, 1.05 equiv) was then added dropwise by a syringe. The solution was stirred at 0° C. for 2.0 hrs, was then allowed to warm to room temperature and stirred at room temperature for 18 hrs. Et3N (23 μL, 0.1 equiv) and methanesulfonyl chloride (13 μL, 0.1 equiv) were added and the mixture was stirred for another 6 h. A saturated solution of NH4Cl (20 mL) was added and stirred at room temperature for 10 min. The layers were separated. The aqueous phase was extracted with DCM (3×30 mL). The combined organic phase were washed with HCl (1N, 20 mL) and water (20 mL) and were dried over anhydrous Na2SO4, concentrated in vacuo to afford 482 mg (yield 93%) of tert-butyl 2-(methylsulfonyloxy)-7-azaspiro[3.5]nonane-7-carboxylate as a white solid.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09226923B2uspto-grants-2016_01